Proven sales leader dedicated to achieving continuous growth in sales revenue. Seeking a challenging role as an Account Executive with a results-driven company. Demonstrated track record of exceeding sales targets and building strong client relationships. Adept at identifying and capitalizing on new business opportunities to drive revenue growth.
Overview
28
28
years of professional experience
Work History
Director, Strategic Accounts
Alexion Pharmaceuticals, AZ Rare Diseases Unit
08.2020 - Current
Lead the development and execution of the comprehensive strategy for target accounts to bring the best value to the customer while advancing the Alexion portfolio of products.
Partner with target healthcare systems and organized customer groups to foster innovation in care and decrease timeline to diagnosis for rare disease patients.
Develop high-performing teams by providing mentorship, guidance, and opportunities for professional growth.
Enhance team collaboration through regular communication, goal setting, and quarterly "One Alexion" meetings.
Deliver on strategic goals by working with cross-functional team and executing a hyper-focused approach.
Cultivate a positive work environment that fosters team engagement through regular communication.
Thrombosis Area Manager
Portola Pharmaceuticals
01.2019 - 08.2020
Launched ANDEXXA (Coagulation Factor Xa) in 20+ institutions throughout Chicago and suburbs, including 5 academic medical centers, 2 VA accounts and several community-based hospitals
Clinical call points: Cardiologists, Stroke neurologists, Interventional Radiologists, Neurosurgeons, Trauma surgeons, Critical Care surgeons, Hospitalists, Emergency Medicine Physicians, Clinical pharmacists, Directors of Pharmacy, P&T members, Stroke and Trauma coordinators
Accomplishments: Ranked top 20% 2019, Q1 2020 216% to goal, Achieved 3 formulary wins, Conducted ICU and ER in-services, Discussed NTAP with KOLs to help them understand the total cost of care.
Hospital Account Manager
Achaogen, Inc.
06.2008 - 01.2019
Launched ZEMDRI (plazomicin) for serious gram negative infections in the Chicago Hospital and Outpatient markets
Call points included: Infectious Disease, Critical Care, Urology, Nephrology, Clinical Pharmacists, DOPs, Case Managers, Discharge planners
Accomplishments: Gained formulary acceptance at large IDN in Chicago, Conducted ICU in-services, Had 1st patient treated in the country, Set up micro testing with several academic centers, Discussed NTAP with KOLs, Provided insurance verification resources to office staff.
Health Systems Manager
Shire/Takeda (Baxalta Pharmaceuticals Legacy)
12.2015 - 06.2018
Launched rare disease products: OBIZUR for acquired hemophilia A and VONVENDI for Von Willebrand Disease, also responsible for ADVATE and FEIBA growth in Chicago/Milwaukee institutions
Call points included: Hematologists, Critical Care physicians, Hematology/Oncology, DOPs, Coagulation pharmacists, clinical coordinators, case managers, P&T members
Accomplishments: 104% to goal for Advate 2017, 106% to goal for FEIBA 2017, Achieved OBIZUR stocking in 90% of target accounts, Ranked 3/16-2016, Ranked 4/30-2017.
Clinical Business Manager
Cubist Pharmaceuticals (Adolor Legacy)
03.2009 - 12.2015
Launched ZERBAXA, a gram-negative antibiotic, launched ENTEREG, an opioid receptor antagonist, launched SIVEXTRO, a gram positive antibiotic, launched DIFICID for C
Difficile infections and grew market for CUBICIN
Territory covered institutions (Hospitals, Infusion Centers, Home Infusion Companies) in Chicago and Milwaukee
Call points: Colon & Rectal Surgeons, General Surgeons, Infectious Disease, Anesthesiologists, Critical Care, DOPS, clinical pharmacists, P&T members, Case Managers, Discharge planners
Accomplishments: Cube of Excellence 2013, Account Manager of the Year 2010, 2014 130% to goal-CUBICIN, 121% to goal-SIVEXTRO, Sales Advisor at Initial Sales training 2011, 2012, Ran ENTEREG workshop at National Sales Meeting 2012, Assisted in the hiring and mentoring of 3 new Clinical Business Managers in the central region.
Launched LEVAQUIN, ULTRACET and REMICADE to Chicago hospitals including academic medical centers and Community based
Call points: Infectious Disease, Critical Care, Emergency medicine, Internal Medicine, Surgeons, Hematology/Oncology, DOPs, Clinical coordinators, P&T members
Accomplishments: Promoted to Senior Institutional Manager-2002, President's Circle Winner-2000, Mentor to Primary Care Representatives-2000-2002, Ranked in top 2% Highest Market Share-LEVAQUIN-2000, 2001, 2002, 2003, Region Account Manager of the Year 2003, 259% to quota for PREVACARE-2006, Account Manager of the Year 2007, Served on Marketing Advisory Board for LEVAQUIN 2000-2003.
Institutional Healthcare Representative
Zeneca Pharmaceuticals
11.1997 - 03.1999
Sold DIPRIVAN, MERREM and CEFOTETAN to Academic centers and Community based hospitals
Associate Director, Clinical Operations at Alexion Pharmaceuticals, Rare Disease Unit of AstraZenecaAssociate Director, Clinical Operations at Alexion Pharmaceuticals, Rare Disease Unit of AstraZeneca
Associate Director, Study Lead Country Operations at AstraZeneca Alexion Rare DiseasesAssociate Director, Study Lead Country Operations at AstraZeneca Alexion Rare Diseases